A meta-analysis comparing the efficacy of five 5-HT3-receptor antagonists (5-HT3-RAs) for acute chemotherapy induced emesis No significant financial relationships to disclose. This is an ASCO Meeting ...

Primary prophylaxis of febrile neutropenia using long-acting granulocyte colony-stimulating factors in female patients receiving dose-dense biweekly chemotherapy in the clinical routine. This is an ...

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections Raichur & Hyderabad, India – ...

Boston, MA, USA: New data presented today to international delegates attending the 14th Annual Meeting of the Multinational Association of Supportive Cancer Care (MASCC), showed that Kytril® ...

Shilpa Medicare has announced its intention to pursue a US approval within the next two years and is actively seeking licensing partners for its ondansetron extended-release injection (OERIS), ...